Steven A. Rosenberg, MD, PhD [clinicaltrials_resource:efe50b829a1b74856f6a7748cd0fdff3]
Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00062036]Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00072085]Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00077532]Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00085462]Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00091104]Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00091338]clinicaltrials:NCT00096382MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00112580]Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma [clinicaltrials:NCT00138229]Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma [clinicaltrials:NCT00357461]clinicaltrials:NCT00704938
overall official [clinicaltrials_vocabulary:overall-official]
Steven A. Rosenberg, MD, PhD [clinicaltrials_resource:efe50b829a1b74856f6a7748cd0fdff3]
Bio2RDF identifier
efe50b829a1b74856f6a7748cd0fdff3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:efe50b829a1b74856f6a7748cd0fdff3
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
sar@mail.nih.gov
last name [clinicaltrials_vocabulary:last-name]
Steven A. Rosenberg, MD, PhD
phone [clinicaltrials_vocabulary:phone]
301-496-4164
role [clinicaltrials_vocabulary:role]
Principal Investigator
identifier
clinicaltrials_resource:efe50b829a1b74856f6a7748cd0fdff3
title
Steven A. Rosenberg, MD, PhD
@en
type
label
Steven A. Rosenberg, MD, PhD [clinicaltrials_resource:efe50b829a1b74856f6a7748cd0fdff3]
@en